GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide (Q42482163)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 5, 2011

Language	Label	Description	Also known as
English	GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide	scientific article published on January 5, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide (English)

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

Laszlo Hegedüs

1

object named as

Laszlo Hegedüs

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Milan Zdravkovic

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Tu Le Thi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Alan C. Moses

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21209033

21 November 2024

Gilbert H. Daniels

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21209033

21 November 2024

language of work or name

0 references

publication date

5 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

full work available at URL

https://academic.oup.com/jcem/article-pdf/96/3/853/9068933/jcem0853.pdf

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21209033

21 November 2024

http://intl-jcem.endojournals.org/cgi/content/abstract/96/3/853

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21209033

21 November 2024

http://academic.oup.com/jcem/article-pdf/96/3/853/9068933/jcem0853.pdf

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

The Journal of Clinical Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

853-860

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.

1

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Medullary thyroid carcinoma

2

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.

3

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Correlation between gender and spontaneous C-cell tumors in the thyroid gland of the Wistar rat

4

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

The effects of xenobiotics on the structure and function of thyroid follicular and C-cells

5

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting

6

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

7

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study

8

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

9

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

10

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

11

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

12

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes

13

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes

14

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

15

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Long-term effects of elevated gastrin levels on calcitonin secretion

16

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules

17

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

18

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Immunohistochemical alterations of C cells in sheep treated with vitamin D

20

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Medullary thyroid cancer: management guidelines of the American Thyroid Association

21

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study

22

1 reference

10.1210/JC.2010-2318

https://api.crossref.org/works/10.1210/JC.2010-2318

21 November 2024

Identifiers

10.1210/JC.2010-2318

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42482163&oldid=2279105951"